[424B5] Wearable Devices Ltd. Prospectus Supplement (Debt Securities)
Wearable Devices (WLDS) amended its ATM program to $3,864,566 of ordinary shares under its Form F-3 with A.G.P., decreasing the prior $7,400,000 limit. Sales, if any, may be made as “at the market offerings” under Rule 415, with A.G.P. acting on a best efforts basis.
The company has sold $1,256,000 to date under the Sales Agreement. A.G.P. will receive a 3.0% commission on gross sales, and will be deemed an underwriter; indemnification applies as customary. WLDS shares trade on Nasdaq at $2.96 per share as of October 28, 2025. The aggregate market value of ordinary shares held by non‑affiliates was $54,829,754 as of October 29, 2025 under Form F‑3 I.B.5, and the company notes it has sold approximately $9,870,000 of securities in the past 12 months, leaving current I.B.5 capacity of $8,404,757.
Wearable Devices (WLDS) ha modificato il suo programma ATM a $3.864.566 di azioni ordinarie in conformità al Form F-3 con A.G.P., riducendo il precedente limite di $7.400.000. Le vendite, se ve ne saranno, possono essere effettuate come "offerte sul mercato" ai sensi della Regola 415, con A.G.P. che opererà in base al miglior sforzo.
L'azienda ha già venduto $1.256.000 fino ad oggi ai sensi dell'Agreement Sales. A.G.P. riceverà una commissione del 3,0% sul valore lordo delle vendite e sarà considerata come un sottoscrittore; l'indennità si applica come di consueto. Le azioni WLDS sono trattate sul Nasdaq a $2,96 per azione al 28 ottobre 2025. Il valore di mercato aggregato delle azioni ordinarie detenute da non affiliati era di $54.829.754 al 29 ottobre 2025 ai sensi del Form F-3 I.B.5, e l'azienda segnala di aver venduto circa $9.870.000 di titoli negli ultimi 12 mesi, restando una capacità I.B.5 attuale di $8.404.757.
Wearable Devices (WLDS) enmendó su programa ATM a $3,864,566 de acciones ordinarias bajo su Formulario F-3 con A.G.P., reduciendo el límite anterior de $7,400,000. Las ventas, si las hubiera, pueden hacerse como "ofertas en el mercado" bajo la Regla 415, con A.G.P. actuando en base al mejor esfuerzo.
La compañía ha vendido $1,256,000 hasta la fecha bajo el Acuerdo de Ventas. A.G.P. recibirá una comisión del 3,0% sobre las ventas brutas, y se le considerará un underwriter; la indemnización se aplica como de costumbre. Las acciones WLDS se negocian en Nasdaq a $2.96 por acción al 28 de octubre de 2025. El valor de mercado agregado de las acciones ordinarias mantenidas por no afiliados era de $54,829,754 al 29 de octubre de 2025 conforme al Form F-3 I.B.5, y la empresa señala que ha vendido aproximadamente $9,870,000 de valores en los últimos 12 meses, quedando una capacidad I.B.5 actual de $8,404,757.
Wearable Devices (WLDS)는 A.G.P.와의 Form F-3에 따른 일반주식의 ATM 프로그램을 $3,864,566로 수정하였고, 이전 한도인 $7,400,000를 감소시켰습니다. 매출은 있을 경우 Rule 415에 따른 "시장 내 공모"로 할 수 있으며, A.G.P.는 최선을 다해 노력하는 방식으로 운영됩니다.
회사는 현재까지 판매 계약에 따라 $1,256,000를 판매했습니다. A.G.P.는 총매출의 3.0%를 커미션으로 받고, 언더라이더로 간주되며, 면책은 관례에 따라 적용됩니다. WLDS 주식은 2025년 10월 28일 기준 Nasdaq에서 주당 $2.96에 거래됩니다. 비계열사가 보유한 일반주식의 총시장가치는 2025년 10월 29일 기준 Form F-3 I.B.5에 따라 $54,829,754였으며, 회사는 지난 12개월 동안 약 $9,870,000의 유가증권을 매도했다고 밝히고 있으며, 현재 I.B.5 용량은 $8,404,757로 남아 있습니다.
Wearable Devices (WLDS) a modifié son programme ATM pour atteindre $3 864 566 d'actions ordinaires conformément à son Formulaire F-3 avec A.G.P., en réduisant la limite précédente de $7 400 000. Les ventes, le cas échéant, peuvent être effectuées en tant que « offres sur le marché » en vertu de la Règle 415, A.G.P. agissant en tant que meilleure-effort.
La société a déjà vendu $1 256 000 à ce jour dans le cadre de l'Accord de Vente. A.G.P. percevra une commission de 3,0% sur le produit brut des ventes et sera considéré comme un souscripteur ; l'indemnisation s'applique comme d'habitude. Les actions WLDS se négocient sur le Nasdaq à $2,96 par action au 28 octobre 2025. La valeur marchande agrégée des actions ordinaires détenues par des non affiliés était de $54 829 754 au 29 octobre 2025 en vertu du Formulaire F-3 I.B.5, et la société indique avoir vendu environ $9 870 000 de valeurs mobilières au cours des 12 derniers mois, laissant une capacité actuelle I.B.5 de $8 404 757.
Wearable Devices (WLDS) hat sein ATM-Programm auf $3.864.566 an Stammaktien gemäß seinem Formular F-3 mit A.G.P. geändert und damit das vorherige Limit von $7.400.000 reduziert. Verkäufe, falls es welche geben sollte, können als »im Markt angebotene Wertpapiere« nach Regel 415 erfolgen, wobei A.G.P. im Rahmen eines Best-Efforts-Vertrages handelt.
Das Unternehmen hat bisher $1.256.000 im Rahmen des Sales Agreement verkauft. A.G.P. erhält eine Provision von 3,0% des Bruttoumsatzes und wird als Underwriter angesehen; Entschädigung gilt wie üblich. WLDS-Aktien handeln an der Nasdaq zum Stand vom 28. Oktober 2025 zu $2,96 pro Aktie. Der aggregierte Marktwert der von Nicht‑Affiliates gehaltenen Stammaktien betrug gemäß Form F-3 I.B.5 am 29. Oktober 2025 $54.829.754, und das Unternehmen weist darauf hin, dass es in den letzten 12 Monaten etwa $9.870.000 an Wertpapieren verkauft hat, was eine aktuelle I.B.5-Kapazität von $8.404.757 hinterlässt.
قامت Wearable Devices (WLDS) بتعديل برنامج ATM الخاص بها ليصل إلى 3,864,566 دولارًا من الأسهم العادية وفقًا للنموذج F-3 مع A.G.P., مع تقليل الحد السابق البالغ 7,400,000 دولار. يمكن أن تتم المبيعات، إن وجدت، كـ "عروض في السوق" وفق القاعدة 415، مع قيام A.G.P. بالعمل وفق أفضل جهد.
حتى تاريخ اليوم، باعت الشركة $1,256,000 بموجب اتفاق المبيعات. ستتلقى A.G.P. عمولة قدرها 3.0% من مجمل المبيعات، وستعتبر مكتتبًا؛ والتعويض سارٍ كما هو customary. يتم تداول أسهم WLDS في Nasdaq بسعر $2.96 للسهم اعتبارًا من 28 أكتوبر 2025. وكانت القيمة السوقية الإجمالية للأسهم العادية المملوكة من قبل غير المرتبطين $54,829,754 حتى 29 أكتوبر 2025 وفقًا للنموذج F-3 I.B.5، وتلاحظ الشركة أنها باعت نحو $9,870,000 من الأوراق المالية في آخر 12 شهرًا، تاركة سعة I.B.5 الحالية قدرها $8,404,757.
- None.
- None.
Insights
WLDS trims ATM size; capacity aligns with I.B.5 limits.
WLDS reduced its at-the-market program to a maximum aggregate offering price of
Compensation is straightforward: a
Actual issuance will depend on market conditions and WLDS’s utilization choices within these disclosed limits. The Nasdaq last sale price was
Wearable Devices (WLDS) ha modificato il suo programma ATM a $3.864.566 di azioni ordinarie in conformità al Form F-3 con A.G.P., riducendo il precedente limite di $7.400.000. Le vendite, se ve ne saranno, possono essere effettuate come "offerte sul mercato" ai sensi della Regola 415, con A.G.P. che opererà in base al miglior sforzo.
L'azienda ha già venduto $1.256.000 fino ad oggi ai sensi dell'Agreement Sales. A.G.P. riceverà una commissione del 3,0% sul valore lordo delle vendite e sarà considerata come un sottoscrittore; l'indennità si applica come di consueto. Le azioni WLDS sono trattate sul Nasdaq a $2,96 per azione al 28 ottobre 2025. Il valore di mercato aggregato delle azioni ordinarie detenute da non affiliati era di $54.829.754 al 29 ottobre 2025 ai sensi del Form F-3 I.B.5, e l'azienda segnala di aver venduto circa $9.870.000 di titoli negli ultimi 12 mesi, restando una capacità I.B.5 attuale di $8.404.757.
Wearable Devices (WLDS) enmendó su programa ATM a $3,864,566 de acciones ordinarias bajo su Formulario F-3 con A.G.P., reduciendo el límite anterior de $7,400,000. Las ventas, si las hubiera, pueden hacerse como "ofertas en el mercado" bajo la Regla 415, con A.G.P. actuando en base al mejor esfuerzo.
La compañía ha vendido $1,256,000 hasta la fecha bajo el Acuerdo de Ventas. A.G.P. recibirá una comisión del 3,0% sobre las ventas brutas, y se le considerará un underwriter; la indemnización se aplica como de costumbre. Las acciones WLDS se negocian en Nasdaq a $2.96 por acción al 28 de octubre de 2025. El valor de mercado agregado de las acciones ordinarias mantenidas por no afiliados era de $54,829,754 al 29 de octubre de 2025 conforme al Form F-3 I.B.5, y la empresa señala que ha vendido aproximadamente $9,870,000 de valores en los últimos 12 meses, quedando una capacidad I.B.5 actual de $8,404,757.
Wearable Devices (WLDS)는 A.G.P.와의 Form F-3에 따른 일반주식의 ATM 프로그램을 $3,864,566로 수정하였고, 이전 한도인 $7,400,000를 감소시켰습니다. 매출은 있을 경우 Rule 415에 따른 "시장 내 공모"로 할 수 있으며, A.G.P.는 최선을 다해 노력하는 방식으로 운영됩니다.
회사는 현재까지 판매 계약에 따라 $1,256,000를 판매했습니다. A.G.P.는 총매출의 3.0%를 커미션으로 받고, 언더라이더로 간주되며, 면책은 관례에 따라 적용됩니다. WLDS 주식은 2025년 10월 28일 기준 Nasdaq에서 주당 $2.96에 거래됩니다. 비계열사가 보유한 일반주식의 총시장가치는 2025년 10월 29일 기준 Form F-3 I.B.5에 따라 $54,829,754였으며, 회사는 지난 12개월 동안 약 $9,870,000의 유가증권을 매도했다고 밝히고 있으며, 현재 I.B.5 용량은 $8,404,757로 남아 있습니다.
Wearable Devices (WLDS) a modifié son programme ATM pour atteindre $3 864 566 d'actions ordinaires conformément à son Formulaire F-3 avec A.G.P., en réduisant la limite précédente de $7 400 000. Les ventes, le cas échéant, peuvent être effectuées en tant que « offres sur le marché » en vertu de la Règle 415, A.G.P. agissant en tant que meilleure-effort.
La société a déjà vendu $1 256 000 à ce jour dans le cadre de l'Accord de Vente. A.G.P. percevra une commission de 3,0% sur le produit brut des ventes et sera considéré comme un souscripteur ; l'indemnisation s'applique comme d'habitude. Les actions WLDS se négocient sur le Nasdaq à $2,96 par action au 28 octobre 2025. La valeur marchande agrégée des actions ordinaires détenues par des non affiliés était de $54 829 754 au 29 octobre 2025 en vertu du Formulaire F-3 I.B.5, et la société indique avoir vendu environ $9 870 000 de valeurs mobilières au cours des 12 derniers mois, laissant une capacité actuelle I.B.5 de $8 404 757.
Wearable Devices (WLDS) hat sein ATM-Programm auf $3.864.566 an Stammaktien gemäß seinem Formular F-3 mit A.G.P. geändert und damit das vorherige Limit von $7.400.000 reduziert. Verkäufe, falls es welche geben sollte, können als »im Markt angebotene Wertpapiere« nach Regel 415 erfolgen, wobei A.G.P. im Rahmen eines Best-Efforts-Vertrages handelt.
Das Unternehmen hat bisher $1.256.000 im Rahmen des Sales Agreement verkauft. A.G.P. erhält eine Provision von 3,0% des Bruttoumsatzes und wird als Underwriter angesehen; Entschädigung gilt wie üblich. WLDS-Aktien handeln an der Nasdaq zum Stand vom 28. Oktober 2025 zu $2,96 pro Aktie. Der aggregierte Marktwert der von Nicht‑Affiliates gehaltenen Stammaktien betrug gemäß Form F-3 I.B.5 am 29. Oktober 2025 $54.829.754, und das Unternehmen weist darauf hin, dass es in den letzten 12 Monaten etwa $9.870.000 an Wertpapieren verkauft hat, was eine aktuelle I.B.5-Kapazität von $8.404.757 hinterlässt.
قامت Wearable Devices (WLDS) بتعديل برنامج ATM الخاص بها ليصل إلى 3,864,566 دولارًا من الأسهم العادية وفقًا للنموذج F-3 مع A.G.P., مع تقليل الحد السابق البالغ 7,400,000 دولار. يمكن أن تتم المبيعات، إن وجدت، كـ "عروض في السوق" وفق القاعدة 415، مع قيام A.G.P. بالعمل وفق أفضل جهد.
حتى تاريخ اليوم، باعت الشركة $1,256,000 بموجب اتفاق المبيعات. ستتلقى A.G.P. عمولة قدرها 3.0% من مجمل المبيعات، وستعتبر مكتتبًا؛ والتعويض سارٍ كما هو customary. يتم تداول أسهم WLDS في Nasdaq بسعر $2.96 للسهم اعتبارًا من 28 أكتوبر 2025. وكانت القيمة السوقية الإجمالية للأسهم العادية المملوكة من قبل غير المرتبطين $54,829,754 حتى 29 أكتوبر 2025 وفقًا للنموذج F-3 I.B.5، وتلاحظ الشركة أنها باعت نحو $9,870,000 من الأوراق المالية في آخر 12 شهرًا، تاركة سعة I.B.5 الحالية قدرها $8,404,757.
Filed Pursuant to Rule 424(b)(5)
Registration No. 333-274841
AMENDMENT NO. 1 DATED OCTOBER 29, 2025
To Prospectus Supplement dated September 25, 2025
(to Prospectus dated October 18, 2023)
Up to $3,864,566
Ordinary Shares
This Amendment No. 1, or the Amendment, amends and supplements the information in the prospectus, dated October 18, 2023, filed with the Securities and Exchange Commission as a part of our registration statement on Form F-3 (File No. 333-274841), as previously supplemented by our prospectus supplement dated September 25, 2025, or collectively the Prior Prospectus, relating to the offer and sale of up to $7,400,000 of our ordinary shares, no par value, or Ordinary Shares, pursuant to the sales agreement, or the Sales Agreement, with A.G.P./Alliance Global Partners, or A.G.P., dated September 25, 2025. This Amendment should be read in conjunction with the Prior Prospectus, and is qualified by reference thereto, except to the extent that the information herein amends or supersedes the information contained in the Prior Prospectus. This Amendment is not complete without and may only be delivered or utilized in connection with the Prior Prospectus and any future amendments or supplements thereto.
We are filing this Amendment to supplement and amend, as of October 29, 2025, the Prior Prospectus to decrease the maximum aggregate offering price of our Ordinary Shares that may be offered, issued and sold under the Sales Agreement from $7,400,000 to $3,864,566. Accordingly, under the Prior Prospectus as amended by this Amendment, we may now offer and sell Ordinary Shares having a maximum aggregate offering price of up to $3,864,566.
Sales of our Ordinary Shares, if any, under the Prior Prospectus and this Amendment, may be made in sales deemed to be “at the market offerings” as defined in Rule 415 promulgated under the Securities Act of 1933, as amended, or the Securities Act. A.G.P. is not required to sell any specific number or dollar amount of securities but will act as a sales agent on a best efforts basis and will use commercially reasonable efforts consistent with its normal trading and sales practices, on mutually agreed terms between A.G.P. and us. There is no arrangement for funds to be received in any escrow, trust or similar arrangement. To date, we have sold an aggregate of $1,256,000 of our Ordinary Shares pursuant to the Sales Agreement.
A.G.P. will be entitled to compensation at a commission rate of 3.0% of the gross sales price per share sold pursuant to the terms of the Sales Agreement. See “Plan of Distribution” beginning on page S-12 of the Prior Prospectus for additional information regarding the compensation to be paid to A.G.P. In connection with the sale of our Ordinary Shares on our behalf, A.G.P. will be deemed to be an “underwriter” within the meaning of the Securities Act, and the compensation of the A.G.P. will be deemed to be underwriting commissions or discounts. We also have agreed to provide indemnification and contribution to A.G.P. with respect to certain liabilities, including liabilities under the Securities Act and the Securities Exchange Act of 1934, as amended.
Our Ordinary Shares are listed on The Nasdaq Capital Market, or Nasdaq, under the symbol “WLDS”. On October 28, 2025, the last reported sale price of our Ordinary Shares on Nasdaq was $2.96 per Ordinary Share.
The aggregate market value of our Ordinary Shares held by non-affiliates as of October 29, 2025, pursuant to General Instruction I.B.5 of Form F-3 is $54,829,754 which was calculated based on 5,820,568 Ordinary Shares outstanding held by non-affiliates and at a price of $9.42 per Ordinary Share, the closing price of our Ordinary Shares on September 12, 2025. We have sold an aggregate of approximately $9,870,000 of securities, including amounts sold under the Prior Prospectus as reduced by this Amendment, pursuant to General Instruction I.B.5. of Form F-3 during the 12-calendar month calendar period that ends on, and includes, the date of this Amendment and, as a result, the capacity to sell securities under our Form F-3 Registration Statement pursuant to General Instruction I.B.5. is currently $8,404,757.
Investing in our Ordinary Shares involves risk. See “Risk Factors” beginning on page S-4 of the Prior Prospectus and in the documents incorporated by reference into the Prior Prospectus for a discussion of information that should be considered in connection with an investment in our Ordinary Shares.
Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or passed upon the adequacy or accuracy of the Prior Prospectus, this Amendment or the accompanying prospectus. Any representation to the contrary is a criminal offense.
A.G.P.
The date of this prospectus supplement is October 29, 2025.
FAQ
What did WLDS change in its ATM program?
How much has WLDS sold under the Sales Agreement so far?
What commission will A.G.P. receive on WLDS ATM sales?
What is WLDS’s remaining Form F-3 I.B.5 capacity?
What is WLDS’s public float per I.B.5 as of October 29, 2025?
What is WLDS’s Nasdaq price reference in the amendment?
What methods may WLDS use to sell shares in this ATM?
